NICE backing for Takeda's Adcetris for rare lymphoma

10th July 2020 Uncategorised 0

Standard of care in untreated systemic anaplastic large cell lymphoma (sALCL) has not changed in several decades

More: NICE backing for Takeda's Adcetris for rare lymphoma
Source: News